Lee W Y, Chiu L C, Yeung J H.Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation[J].Food Chem Toxicol, 2008, 46(1):328.
Efferth T, Kahl S, Paulus K, et al. Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells[J]. Mol Cancer Ther, 2008, 7(1):152.
[5]
YuanS L, Wang X J, Wei Y Q. Anticancer effect of tanshinone and its mechanisms[J].Chin J Cancer, 2003, 22(12):1363.
[6]
Holland J F, Bast R C, Morton D L. Cancer Medicine[M].4 ed. Baltimore: Williams ＆ Wilkins, 1997:181.
[7]
Bian W, Chen F, Bai L, et al. Dihydrotanshinone I inhibits angiogenesis both in vitro and in vivo[J]. Acta Biochim Biophys Sin, 2008, 40(1):1.
[8]
Dat N T, Jin X, Lee J H, et al. Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1[J]. J Nat Prod. 2007, 70(7):1093.
[9]
Hur J M, Shim J S, Jung H J, et al. Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro[J]. Exp Mol Med, 2005, 37(2): 33.
[10]
Nizamutdinova I T, Lee G W, Lee J S, et al. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules[J]. Carcinogenesis, 2008, 29(10):1885.
[11]
Ding M, Zhao G R, Yuan Y J, et al. Aqueous extract of Salvia miltiorrhoza regulates adhesion molecule expression of tumor necrosis factor alpha-induced endothelial cells by blocking activation of nuclear factor kappaB[J]. J Cardiovasc Pharmacol, 2005, 45(6):516.
[12]
Zhou Z, Liu Y, Miao A D, et al. Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells[J]. Eur J Pharmacol, 2005, 513(1/2):1.
[13]
Zhou Z, Liu Y, Miao A D, et al. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells[J]. J Cell Biochem, 2005, 96(1):109.
Wang X, Bastow K F, Sun C M, et al. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza[J]. J Med Chem, 2004, 47(23):5816.
[16]
Chang J Y, Chang C Y, Kuo C C, et al. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and resistant human tumor cells[J]. Mol Pharmacol, 2004, 65(1):77.
[17]
Don M J, Shen C C, Lin Y L, et al. Nitrogen-containing compounds from Salvia miltiorrhiza[J]. J Nat Prod, 2005, 68(7):1066.
Han J Y, Fan J Y, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion[J]. Pharmacol Ther, 2008, 117(2):280.
[25]
Zhou Z T, Yang Y, Ge J P.The preventive effect of salvianolic acid B on malignant transformation of DMBA-induced oral premalignant lesion in hamsters[J].Carcinogenesis, 2006, 27(4):826.
[26]
Lee Y J, Kao E S, Chu C Y, et al. Inhibitory effect of ailanthoidol on 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion in mouse skin[J]. Oncol Rep, 2006, 16(4):921.
Mosaddik M A. In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells[J]. Phytomedicine, 2003, 10(8):682.
[29]
Lee D S, Lee S H. Biological activity of dihydrotanshinone I: Effect on apoptosis[J]. J Biosci Bioeng, 2000, 89(3):292.
Liu J J, Lin D J, Liu P Q, et al. Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro[J]. J Biomed Sci, 2006,13(6):813.
